SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001214659-21-013618
Filing Date
2021-12-27
Accepted
2021-12-27 06:06:38
Documents
8

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 j1223210sc13da4.htm SC 13D/A 67151
2 GRAPHIC ex99_b1.jpg GRAPHIC 132316
3 GRAPHIC ex99_b2.jpg GRAPHIC 142052
4 GRAPHIC ex99_b3.jpg GRAPHIC 16327
5 GRAPHIC ex99_b4.jpg GRAPHIC 94301
6 GRAPHIC ex99_b5.jpg GRAPHIC 176838
7 GRAPHIC ex99_b6.jpg GRAPHIC 66874
8 GRAPHIC ex99_b7.jpg GRAPHIC 54535
  Complete submission text file 0001214659-21-013618.txt   1010250
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Subject) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90395 | Film No.: 211518848
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11 SUMMIT LANE GREENVILLE DE 19807
Business Address
Grant Stuart M. (Filed by) CIK: 0001783415 (see all company filings)

Type: SC 13D/A